News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
766,853 Results
Type
Article (53980)
Company Profile (299)
Press Release (712574)
Multimedia
Podcasts (74)
Webinars (13)
Section
Business (221054)
Career Advice (2919)
Deals (37657)
Drug Delivery (119)
Drug Development (86718)
Employer Resources (185)
FDA (17210)
Job Trends (16051)
News (373443)
Policy (35994)
Tag
Academia (2923)
Academic (1)
Accelerated approval (5)
Adcomms (27)
Allergies (93)
Alliances (53571)
ALS (98)
Alzheimer's disease (1478)
Antibody-drug conjugate (ADC) (143)
Approvals (17185)
Artificial intelligence (280)
Autoimmune disease (24)
Automation (16)
Bankruptcy (391)
Best Places to Work (12233)
BIOSECURE Act (20)
Biosimilars (115)
Biotechnology (212)
Bladder cancer (82)
Brain cancer (30)
Breast cancer (296)
Cancer (2376)
Cardiovascular disease (196)
Career advice (2455)
Career pathing (33)
CAR-T (162)
Cell therapy (455)
Cervical cancer (20)
Clinical research (70275)
Collaboration (883)
Compensation (536)
Complete response letters (26)
COVID-19 (2802)
CRISPR (47)
C-suite (261)
Cystic fibrosis (103)
Data (2245)
Decentralized trials (2)
Denatured (22)
Depression (52)
Diabetes (287)
Diagnostics (6799)
Digital health (19)
Diversity (9)
Diversity, equity & inclusion (45)
Drug discovery (130)
Drug pricing (118)
Drug shortages (28)
Duchenne muscular dystrophy (100)
Earnings (92327)
Editorial (43)
Employer branding (24)
Employer resources (158)
Events (123049)
Executive appointments (768)
FDA (18501)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (788)
Gene editing (115)
Generative AI (25)
Gene therapy (336)
GLP-1 (808)
Government (4875)
Grass and pollen (6)
Guidances (61)
Healthcare (20240)
Huntington's disease (24)
IgA nephropathy (30)
Immunology and inflammation (137)
Indications (30)
Infectious disease (2957)
Inflammatory bowel disease (147)
Inflation Reduction Act (9)
Influenza (55)
Intellectual property (99)
Interviews (562)
IPO (17179)
IRA (47)
Job creations (4248)
Job search strategy (2030)
Kidney cancer (11)
Labor market (38)
Layoffs (522)
Leadership (23)
Legal (8968)
Liver cancer (81)
Lung cancer (340)
Lymphoma (156)
Machine learning (7)
Management (62)
Manufacturing (325)
MASH (73)
Medical device (14191)
Medtech (14196)
Mergers & acquisitions (21017)
Metabolic disorders (747)
Multiple sclerosis (86)
NASH (23)
Neurodegenerative disease (107)
Neuropsychiatric disorders (32)
Neuroscience (2066)
NextGen: Class of 2025 (7168)
Non-profit (4913)
Now hiring (39)
Obesity (399)
Opinion (259)
Ovarian cancer (77)
Pain (95)
Pancreatic cancer (86)
Parkinson's disease (158)
Partnered (21)
Patents (244)
Patient recruitment (113)
Peanut (51)
People (62783)
Pharmaceutical (68)
Pharmacy benefit managers (19)
Phase I (21818)
Phase II (30783)
Phase III (23074)
Pipeline (1225)
Policy (158)
Postmarket research (2966)
Preclinical (9393)
Press Release (71)
Prostate cancer (111)
Psychedelics (38)
Radiopharmaceuticals (260)
Rare diseases (417)
Real estate (6602)
Recruiting (72)
Regulatory (24392)
Reports (47)
Research institute (2580)
Resumes & cover letters (457)
Rett syndrome (5)
RNA editing (5)
RSV (46)
Schizophrenia (79)
Series A (138)
Series B (89)
Service/supplier (15)
Sickle cell disease (58)
Special edition (16)
Spinal muscular atrophy (159)
Sponsored (32)
Startups (3913)
State (2)
Stomach cancer (16)
Supply chain (73)
Tariffs (43)
The Weekly (50)
Vaccines (770)
Venture capitalists (42)
Weight loss (275)
Women's health (36)
Worklife (19)
Date
Today (174)
Last 7 days (898)
Last 30 days (2778)
Last 365 days (34376)
2025 (11173)
2024 (36870)
2023 (41851)
2022 (53156)
2021 (57859)
2020 (56709)
2019 (49914)
2018 (37817)
2017 (34756)
2016 (34879)
2015 (41055)
2014 (35374)
2013 (30825)
2012 (32824)
2011 (33433)
2010 (31843)
Location
Africa (941)
Alabama (54)
Alaska (7)
Arizona (250)
Arkansas (14)
Asia (42938)
Australia (7752)
California (6272)
Canada (2040)
China (545)
Colorado (275)
Connecticut (290)
Delaware (153)
Europe (95491)
Florida (922)
Georgia (216)
Idaho (61)
Illinois (575)
India (28)
Indiana (318)
Iowa (11)
Japan (166)
Kansas (106)
Kentucky (25)
Louisiana (11)
Maine (70)
Maryland (930)
Massachusetts (4763)
Michigan (243)
Minnesota (412)
Mississippi (2)
Missouri (88)
Montana (31)
Nebraska (25)
Nevada (63)
New Hampshire (68)
New Jersey (1781)
New Mexico (30)
New York (1778)
North Carolina (1069)
North Dakota (9)
Northern California (2726)
Ohio (212)
Oklahoma (14)
Oregon (37)
Pennsylvania (1397)
Puerto Rico (13)
Rhode Island (35)
South America (1321)
South Carolina (22)
South Dakota (1)
Southern California (2347)
Tennessee (104)
Texas (926)
United States (23955)
Utah (186)
Virginia (152)
Washington D.C. (66)
Washington State (574)
West Virginia (3)
Wisconsin (58)
766,853 Results for "prophase labs inc formerly known as quigley corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
ProPhase Labs, Inc. Announces Financial Results for the Year Ended December 31, 2024
April 1, 2025
·
21 min read
Press Releases
ProPhase Labs Inc. to Present 2024 Year End Financial Results on March 31, 2025
March 28, 2025
·
1 min read
Press Releases
ProPhase Labs to Present at the Investor Summit Virtual on March 11
March 10, 2025
·
1 min read
Press Releases
ProPhase Labs hires Stuart Hollenshead as COO, the former COO and CBO of Barstool Sports
February 18, 2025
·
9 min read
Business
Prophase Labs Inc. To Present First Quarter 2024 Financial Results on May 9
ProPhase Labs Inc., announced that they will be presenting first quarter 2024 financial results on a virtual conference call hosted by Renmark Financial on May 9, 2024 at 11:00 am EDT.
May 2, 2024
·
1 min read
Press Releases
ProPhase Labs Inc. to Present Third Quarter 2024 Financial Results on November 13, 2024
November 11, 2024
·
1 min read
Press Releases
ProPhase Labs Announces Closing of $23.6 Million Sale of Pharmaloz Manufacturing to Houston-Based Private Equity Firm
January 22, 2025
·
6 min read
Business
ProPhase Labs Ushers in New Genomics Era with Jason Karkus at the Helm of Nebula Genomics
ProPhase Labs, Inc. today reported that Jason Karkus, one of the driving forces behind ProPhase Diagnostics, becomes President of Nebula Genomics, a wholly-owned subsidiary of ProPhase Labs.
January 30, 2024
·
5 min read
Press Releases
ProPhase Labs Announces Excellent Progress with Crown Medical Collections Targeting Over $50 Million in Net Near-Term Cash Recovery from COVID-19 Receivables
February 21, 2025
·
6 min read
Business
ProPhase Labs Announces Financial Results for the Three Months Ended March 31, 2024, and Highlights Significant Progress in its Strategic Initiatives.
ProPhase Labs, Inc. (NASDAQ: PRPH) (“ProPhase” or the “Company”), a next-generation biotech, genomics, and diagnostics company, today reported its financial and operational results for the three months ended March 31, 2024.
May 9, 2024
·
24 min read
1 of 76,686
Next
